Loading...
•
Sep 30, 2023
Amedisys Q3 2023 Earnings Report
Amedisys reported slight revenue decrease but increased net income in Q3 2023, while adjusting for non-GAAP measures due to merger transactions.
Key Takeaways
Amedisys reported a slight decrease in net service revenue to $556.2 million, compared to $558.0 million in the same quarter of the previous year. Net income attributable to Amedisys, Inc. increased to $26.0 million from $25.6 million in 2022. Adjusted net income per diluted share was $0.98, down from $1.15 in the prior year.
Net service revenue decreased slightly to $556.2 million.
Net income attributable to Amedisys, Inc. increased to $26.0 million.
Adjusted EBITDA was $57.9 million, compared to $61.5 million in 2022.
Adjusted net income per diluted share decreased to $0.98.
Forward Guidance
Amedisys will not conduct a quarterly earnings call due to the pending merger with UnitedHealth Group Incorporated.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...